Status:
COMPLETED
A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Novo Nordisk A/S
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The hypothesis is that an optimal formulation of fast acting and intermediary acting insulin analogues will improve post prandial glycaemic control in patients with type 1 diabetes
Detailed Description
This trial is a single centre, open-label, randomised 4 period cross-over trial, comparing the pk and pd profiles of IAsp, BIAsp 50, BIAsp 70 and Fast-acting Human Insulin after a standard test meal i...
Eligibility Criteria
Inclusion
- Informed consent obtained before any trial-related activities.
- Diagnosed type 1 diabetes before the age of 40 and on insulin treatment within one year of diagnosis.
- Insulin treatment of any regime for more than one year at time of inclusion.
- Total insulin demand ≥ 0,4 U/IU/kg/24 hrs
- HbA1c between 7% and 12% (both values included).
- Age ≥ 18 years.
- BMI between 18 and 35 kg /m2 (including both values).
Exclusion
- Known or suspected allergy to trial product(s) or related products.
- Recurrent major hypoglycaemic episodes.
- Heart: Unstable Angina Pectoris, AMI \< 12 months or heart insufficiency classified according to NYHA III-IV
- Blood Pressure: Severe uncontrolled hypertension with BP \> 180/110 mmHg, sitting
- Liver: Impaired hepatic function corresponding to serum-ALAT or basic phosphatase \> 2 x upper reference limit of the local laboratory.
- Kidneys: Impaired renal function corresponding to serum-creatinin \> 150 μmol/l according to the local laboratory.
- Any disease judged by the investigator to affect the trial.
- Pregnancy, breast-feeding or the intention of becoming pregnant or fertile women not using adequate contraceptive measures - adequate contraceptive method is sterilisation, hysterectomy or current use of contraceptive pills or intra uterine device.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00888732
Start Date
June 1 2009
End Date
June 1 2010
Last Update
April 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept of Medicine M, Aarhus University Hospital
Aarhus, Denmark, 8000